Illumina corporate policies outline how our business principles align with our core values, ethical responsibilities, and legal obligations. These policies demonstrate our commitment to operate with the highest standards of excellence, while delivering integrated solutions that advance the understanding of genetics and health.
Since 2008, Illumina appointed an Ethics Advisory Board (EAB) to ensure Illumina is practicing fair and ethical values. The EAB meets as necessary, but at least twice a year, to advise and provide recommendations regarding ethical issues involving Illumina’s existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethics issues, policies, and regulations that are relevant to the genomic industry.